Investment
Features
FeesSafety
Academy
More
Pluang+

MSA Safety to present at two major investor conferences in September 2026

Market News
03 Sep 2026
PRNewsWire
View Source
Neutral
pluang ai news

MSA Safety Incorporated announced it will participate in the Jefferies Global Industrials Conference on September 10, 2026, with a webcast presentation and fireside chat featuring CEO Steve Blanco and CFO Julie Beck. Additionally, CFO Julie Beck will attend the D.A. Davidson 25th Annual Diversified Industrials & Services Conference on September 25, 2026, for one-on-one investor meetings. These events provide MSA an opportunity to showcase its leadership in industrial safety technology and engage with investors. Webcast sessions will be available for 90 days on MSA's investor relations website.

More News

Kazia Therapeutics advances cancer drug trials with strong financial backing and upcoming earnings report.

Kazia Therapeutics advances cancer drug trials with strong financial backing and upcoming earnings report.

Kazia Therapeutics is progressing its main cancer drug candidate, paxalisib, into Phase 2 trials for colorectal cancer and planning a new breast cancer study. The company recently raised $40 million to support these developments and maintains a stron...

Company Fundamentals
Bullish
45 minutes ago
Hutchison China MediTech upgraded to Buy after $1.3B GSK licensing deal for cancer drug.

Hutchison China MediTech upgraded to Buy after $1.3B GSK licensing deal for cancer drug.

Hutchison China MediTech Limited (HCM) received a Buy rating upgrade from Daiwa with a new price target of $18.50 following a major licensing deal with GSK. The agreement grants GSK exclusive rights to commercialize HCM's experimental cancer therapy ...

Analyst Insights
Bullish
2 hours ago
Duluth Holdings beats Q2 EPS estimates with $0.50, driven by tariff refunds and strategic product focus.

Duluth Holdings beats Q2 EPS estimates with $0.50, driven by tariff refunds and strategic product focus.

Duluth Holdings reported a strong Q2 earnings per share (EPS) of $0.50, far exceeding the consensus estimate of -$0.01, largely due to $0.44 per share from tariff refunds. Revenue reached $121.39 million, beating estimates but declining from the prev...

Company Fundamentals
Bullish
2 hours ago
Estée Lauder announces leadership changes amid insider stock sale and high valuation metrics.

Estée Lauder announces leadership changes amid insider stock sale and high valuation metrics.

Estée Lauder Companies recently appointed new brand leaders, signaling strategic shifts in its competitive beauty market. An insider executive sold 7,766 shares worth over $802,000, leaving no remaining holdings. The company shows a high P/E ratio of...

Market News
Neutral
2 hours ago
HUTCHMED stock jumps 17.8% on $1.3B GSK licensing deal for cancer therapy

HUTCHMED stock jumps 17.8% on $1.3B GSK licensing deal for cancer therapy

HUTCHMED's shares surged 17.77% after announcing a major licensing deal with GSK for its preclinical cancer drug HMPL-A830. GSK gets exclusive rights outside Greater China, paying $110 million upfront plus up to $1.295 billion in milestone payments. ...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App